A reverse vaccinology approach for the identification of potential vaccine candidates from leishmania spp

Applied Biochemistry and Biotechnology

Volumn 167, Issue 5, 2012, Pages 1340-1350

  John, Lijo ^a   John, Georrge J ^a   Kholia, Trupti ^a  

^a Christ College   (India)

Author keywords

Epitope prediction; Leishmaniasis; Major histocompatibility complex (MHC); Reverse vaccinology; Transmembrane helices

Indexed keywords

ANIMAL MODEL; BINDING EFFICIENCY; CLASS II; CLINICAL MANIFESTATION; CLINICAL USE; CONVENTIONAL METHODS; IN-SILICO; IN-VIVO EXPERIMENTS; LEISHMANIA; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIASIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS; MOLECULAR MIMICRY; PATHOGENIC SPECIES; PLASMA MEMBRANE PROTEIN; SUB-CELLULAR; TRANSMEMBRANE HELICES; VACCINOLOGY; VISCERAL LEISHMANIASIS;

ANTIGENS; CELL MEMBRANES; GENES; VACCINES;

PROTEINS;

GLYCOSOMAL MEMBRANE PROTEIN; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA B14 ANTIGEN; HLA B51 ANTIGEN; LEISHMANIA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE LIKE PROTEIN; PHOSPHOGLYCAN BETA 1,3 GALACTOSYLTRANSFERASE 4; PROTEOPHOSPHOGLYCAN PPG1; PROTEOPHOSPHOGLYCAN PPG4; PROTEOPHOSPHOGLYCAN PPG5; TUZIN; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; ANIMALS; COMPUTATIONAL BIOLOGY; HUMANS; LEISHMANIA; MICE; MOLECULAR SEQUENCE DATA; PROTOZOAN PROTEINS; VACCINES;

ANIMALIA; LEISHMANIA INFANTUM; LEISHMANIA MAJOR;

EID: 84866369161     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-012-9649-0     Document Type: Conference Paper

References (43)

1. Fauci, A. (2008). Harrison's principles of internal medicine (17th ed.). NY: McGraw-Hill Medical.
2. Handman, E. (1999). Advances in Parasitology, 44, 1-39.
3. Awasthi, A., Mathur, R., & Saha, B. (2004). Indian Journal of Medical Research, 119, 238-258.
4. Vanloubbeeck, Y., & Jones, D. (2004). Annals of the New York Academy of Sciences, 1026, 267-272.
5. Liese, J., Schleichera, U., & Bogdan, C. (2008). Immunobiology, 213, 377-387.
6. Murray, H., et al. (2005). Lancet, 366, 1561-1577.
7. Croft, S., Sundar, S., & Fairlamb, H. (2006). Clinical Microbiology Reviews, 19, 111-126.
8. Rodriguez-Cortes, A., et al. (2007). Vaccine, 25, 7962-7971.
9. Reithinger, R., et al. (2007). The Lancet Infectious Diseases, 7, 581-596.
10. Adler, S., & Gunders, A. E. (1964). Transactions of the Royal Society of Tropical Medicine and Hygiene, 58, 274-277.
11. Mauel, J., & Behin, R. (1982). In S. Cohen & K. S. Waren (Eds.), Immunity to Parasitic Infections (pp. 3443-3463). Oxford: Blackwell Sci.
12. Lainson, R., & Bray, R. S. (1966). Transactions of the Royal Society of Tropical Medicine and Hygiene, 60, 526-532.
13. Lainson, R., & Shaw, J. J. (1966). Transactions of the Royal Society of Tropical Medicine and Hygiene, 60, 533-535.
14. Lainson, R., & Shaw, J. J. (1977). The Journal of Tropical Medicine and Hygiene, 80, 29-35.
15. Lujan, R., Chapman,W. L., Jr., Hanson,W. L., & Dennis, V. A. (1990). Journal of Parasitology, 76, 594-597.
16. Porrozzi, R., et al. (2004). The American Journal of Tropical Medicine and Hygiene, 71, 297-305.
17. Gicheru, M., Olobo, J. O., & Anjili, C. O. (1997). Experimental Parasitology, 85, 109-116.
18. Alexander, J., & Phillips, R. S. (1978). Experimental Parasitology, 45, 93-100.
19. Perez, H., Arredondo, B., & Machado, R. (1979). Experimental Parasitology, 48, 9-14.
20. Alexander, J. (1982). Transactions of the Royal Society of Tropical Medicine and Hygiene, 76, 646-649.
21. Alexander, J. (1988). Parasitology, 96, 297-302.
22. Bebars, M. A., et al. (2000). Journal of the Egyptian Society of Parasitology, 30, 137-156.
23. Veras, P., et al. (1999). Memorias do Instituto Oswaldo Cruz, 94, 491-496.
24. McMahon-Pratt, D., & Alexander, J. (2004). Immunological Reviews, 201, 206-224.
25. Kedzierski, L., Zhu, Y., & Handman, E. (2006). Parasitology, 133, S87-S112.
26. Rinaudo, C. D., Telford, J. L., Rappuoli, R., & Seib, K. L. J. (2009). Clin Invest, 119, 2515-2525.
27. Altschul, S. F., et al. (1990). Journal of Molecular Biology, 215, 403-410.
28. Horton, P., et al. (2007). Nucleic Acid Research, 37, W585-W587.
29. Krogh, A., Larsson, B., von Heijne, G., & Sonnhammer, E. L. L. (2001). Journal of Molecular Biology, 305(3), 567-580.
30. Pizza, M., et al. (2000). Science, 287, 1816-1820.
31. Parker, K. C., Bednarek, M. A., & Coligan, J. E. (1994). Journal of Immunology, 152, 163-175.
32. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A., & Stevanovic, S. (1999). Immunogenetics, 50, 213-219.
33. Singh, H., & Raghava, G. P. S. (2003). Bioinformatics, 19, 1009-1014.
34. Singh, H., & Raghava, G. P. S. (2001). Bioinformatics, 17, 1236-1237.
35. Wilson, C., Tiwana, H., & Ebringer, A. (2000). Microbes and Infection, 2, 1489-1496.
36. Nachamkin, I., Allos, B. A., & Ho, T. (1998). Clinical Microbiology Reviews, 11, 555-567.
37. Weber, C. A., Mehta, P. J., Ardito, M., Moise, L., Martin, B., & De Groot, A. S. (2009). Advanced Drug Delivery Reviews, 61, 965-976.
38. Santarém, N., Silvestre, R., Tavares, J., Silva, M., Cabral, S., Maciel J., Cordeiro-da-Silva, A. (2007). Journal of Biomedicine and Biotechnology 85154.
39. Horwitz, M. A., Harth, G., Dillon, B. J., & Maslesa-Galic, S. (2005). Infection and Immunity, 73(8), 4676-4683.
40. Neves, B. M., et al. (2010). American Journal of Pathology, 177(6), 2898-2911.
41. McKean, P. G., Denny, P. W., Knuepfer, E., Keen, J. K., & Smith, D. F. (2001). Cellular Microbiology, 3 (8), 511-523.
42. Peters, C., Stierhof, Y. D., & Ilg, T. (1997). Infection and Immunity, 65(2), 783-786.
43. Seebeck, T., Schaub, R., & Johner, A. (2004). Current Molecular Medicine, 4(6), 585-599.